Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $3.09 Million - $5.74 Million
-24,436 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$225.82 - $368.51 $324,954 - $530,285
-1,439 Reduced 5.56%
24,436 $6.21 Million
Q3 2021

Oct 21, 2021

SELL
$221.9 - $484.47 $1,109 - $2,422
-5 Reduced 0.02%
25,875 $9.96 Million
Q2 2021

Aug 10, 2021

BUY
$129.91 - $234.98 $1.5 Million - $2.72 Million
11,560 Added 80.73%
25,880 $6.08 Million
Q4 2020

Feb 11, 2021

BUY
$65.74 - $169.86 $941,396 - $2.43 Million
14,320 New
14,320 $1.65 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Strategic Advisors LLC Portfolio

Follow Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.